Aorto-iliac Occlusion Treatment With ShorT Unibody aorTic Endograft - ASTUTE Study

Inclusion Criteria: * Age \>18; * Both sex; * Preoperative 2.5mm CTA available; * Written informed consent; * Patients affected by AIOD classified as TASC B (with aortic involvement) C or D involving aortic bifurcation and or the first 5mm of one of both common iliacs; * Treated in the coordinator center or in one of the study's participating center's; * With a calcium volume in target zone based on real lumen of less than 20% and absence of circumferential calcifications; * Minimum follow-up requested: 3-months, 12-18 months and 5-years CTA; clinical and DUS examination at 6- and 12- and 36-months after the intervention and yearly thereafter. Exclusion Criteria: * Age\<18; * No preoperative 2.5mm CTA available; * Refused to sign the informed consent; * Treated outside the coordinator centers or in one of the study's participating centers; * Refusal to adhere to the requested follow-up; * Patients affected by AIOD classified as TASC A or not involving aortic bifurcation or the first 5mm of one of both common iliacs; * With a calcium volume in target zone based on real lumen of more than 20% and presence of circumferential calcifications;